570 A phase I study to determine the safety and pharmacokinetics of intravenous administration of SB715992 on a once weekly for three consecutive weeks schedule in patients with refractory solid tumors
H. Burris III, P. LoRusso, S. Jones, J. McCormick, N. Willcutt, J. Hodge, P. Bush, L. Pandite, J. Sabry, P. HoVolume:
1
Année:
2003
Langue:
english
DOI:
10.1016/s1359-6349(03)90602-1
Fichier:
PDF, 327 KB
english, 2003
File converter
Plus de résultats de recherche
More benefits 
